Cohort | Group | n (F/M) | Age | MMSE | Aβ1-42/1-40 | P-tau181 | T-tau |
---|---|---|---|---|---|---|---|
TRIAD CSF | Young | 5 (3/2) | 23 (1, 22–24)a,b,c,d | 30 (0, 30–30) | 0.095 (0.010, 0.088–0.10)b,d | 24 (7, 23–31)b | 191 (36, 161–222)b |
CU− | 15 (11/4) | 71 (5, 68–74)a | 29 (1, 28–30) | 0.093 (0.010, 0.082–0.098)b,d | 33 (10, 29–42)b | 252 (72, 199–335)b | |
CU+6 | 10 (5/5) | 73 (3, 70–76)a | 29 (1, 29–30) | 0.059 (0.011, 0.046–0.067)a,b | 52 (22, 41–72)b | 395 (126, 292–488)b | |
CI− | 12 (6/6) | 65 (8, 60–68) | 29 (3, 26–30) | 0.095 (0.014, 0.091–0.099)b | 33 (13, 19–36)b | 250 (88, 159–294)b | |
CI+8 | 28 (11/17) | 68 (9, 60–77) | 25 (4, 21–29) | 0.042 (0.009, 0.037–0.051) | 82 (50, 64–118) | 551 (323, 398–778) |